Back to Search

ERIC MCGARY, MD

MD

Hematology & Oncology Physician

NPI: 1851430557IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

A66028(CA)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

TULANE UNIVERSITY SCHOOL OF MEDICINE

Class of 1997

Research & Publications (7)

Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
PMID 15009722·J Invest Dermatol·2004
7-preclinical
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
PMID 14695161·Clin Cancer Res·2003
7-preclinical
Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
PMID 12429650·Clin Cancer Res·2002
7-preclinical
Mechanisms of action of rapamycin in gliomas.
PMID 15701277·Neuro Oncol·2005
7-preclinical
Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
PMID 15671555·Clin Cancer Res·2005
8-other
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
PMID 15123733·J Clin Oncol·2004
7-preclinical
Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
PMID 12939465·Mol Cancer Ther·2003
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
6041 CADILLAC AVE
LOS ANGELES, CA 90034

Location

Practice Location

6041 CADILLAC AVE, LOS ANGELES, CA
(323) 857-2000

Quick Facts

NPI
1851430557
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
29
Publications
7

Are you this provider?

Claim Your Profile